We have located links that may give you full text access.
CASE REPORTS
JOURNAL ARTICLE
Central retinal vein occlusion.
Journal of Ophthalmic Nursing & Technology 1993 March
1. CRVO (central retinal vein occlusion) is of two types: ischemic (hemorrhagic retinopathy) and nonischemic (venous stasis retinopathy). 2. Retinal capillary obliteration is a hallmark of retinal ischemia. Fluorescein fundus angiography gives the most valuable information in the differentiation of CRVO into it two types. The ischemic type is in sharp contrast to the nonischemic because there is significant retinal capillary obliteration in ischemic CRVO. 3. The relative afferent pupillary defect (RAPD) is very helpful in separating the ischemic type from the nonischemic type, during both the early and the late stages of the disease. There is a positive RAPD in hemorrhagic retinopathy. 4. The most serious complication of CRVO is the development of various types of ocular neovascularization.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app